Clinical Trials Browser

Withdrawn × OTHER × sitravatinib × Clear all

NCT05614453 2023-06-29

ITTACC

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT05419817 2023-02-27

Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System

Phase 2 Withdrawn

Endometrial Neoplasms